Back to Atlas
APotentially durableResearch-only / high verification need
CMP-0050
Approved in limited indications
Fluoxymesterone / Halotestin
Ergogenic / AAS
Strength/aggression/androgenic-performance emphasis with limited mass gain
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- 17α-alkylated AAS
- Primary mechanism
- Androgen receptor agonist; A:A ratio often cited ~1900:850
- Primary market use
- Androgen therapy/anemia history; performance misuse
Pharmacology
- Molecular weight (Da)
- 336.44
- Oral bioavailability
- Oral; clinically active 17α-alkylated steroid
- Half-life
- ~9.2 h
- Route tags
- Route-dependent / verify
- Evidence level
- Approved/historical
- Clinical status
- Approved in limited indications
- Value-for-money score
- 4 / 10
Reported protocol signal
No popular protocol verified yet; keep as reference compound until protocol signal is added.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
High anabolic potency in classic assays but strongly androgenic; ratio is preclinical and not a safety guide.